about
Examining the Behaviour subscale of the Hypoglycaemia Fear Survey: an international study.Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial.The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.Uptake and Effects of the e-Vita Personal Health Record with Self-Management Support and Coaching, for Type 2 Diabetes Patients Treated in Primary Care.Monitoring health related quality of life in adolescents with diabetes: a review of measures.Barriers to insulin initiation and intensification and how to overcome them.The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis.Ethnic aspects of emotional distress in patients with diabetes--the Amsterdam Health Monitor Study.Does hypoglycaemia affect the improvement in QoL after the transition to insulin in people with type 2 diabetes?Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume.HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.Effects of self-monitoring of glucose on distress and self-efficacy in people with non-insulin-treated Type 2 diabetes: a randomized controlled trial.Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functionsEicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study.Comment on 'psychological distress in patients with cancer: is screening the effective solution?'.Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.Associations between depressive symptoms and insulin resistance: the Hoorn Study.Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes.Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary care.Combined bedtime insulin--daytime sulphonylurea regimen compared with two different daily insulin regimens in type 2 diabetes: effects on HbA1c and hypoglycaemia rate--a randomised trial.Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study.Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial.Differential associations between depressive symptoms and glycaemic control in outpatients with diabetes.Light therapy: is it safe for the eyes?Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study.Patients' intentions to inform relatives about Type 2 diabetes risk: the role of worry in the process of family risk disclosure.Symptom burden and its association with change in glucose metabolism status over a 7-year period: the Hoorn Study.Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus.Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy.Diabetic encephalopathy: A concept in need of a definition.Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.Health-related quality of life in the first year following diagnosis of Type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study.Hypoglycaemia induces emotional disruption.Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research ConCeiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands.Validation of a quick screening instrument for measuring fear of hypoglycaemia in persons with diabetes.35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999Looking back on 25 years of the PSAD study groupBack to the future: 25 years of 'Guidelines for encouraging psychological well-being' among people affected by diabetes
P50
Q30456407-C7669F13-59EE-42B9-BFDB-284E14C254DEQ34641574-5FEACBAA-8888-4EBF-AF8B-90ABA3EF66CAQ36223689-B9497037-3157-436C-AE4A-101F87DBA8A8Q36587082-0382A2D2-4F67-4748-8337-E6BC34C023C9Q36798040-AB63BA3B-E34F-4D9F-BDAD-7D142A29D993Q37596577-02B08DB6-E618-4E64-8451-3E67AEDB0667Q38629235-E738D6AD-9033-410C-8EAC-93265F4426D2Q39365890-E1E88E5B-7D32-458C-92BE-6F15ABC5F501Q40084842-3796074B-515A-40EC-BAEC-EEEF7A366187Q40206976-8E9255DA-15BA-4FE2-B02B-347A13FFDD57Q41521272-3A3C8464-986F-44DD-91C5-D836D4B89251Q41589246-8F1F8396-8861-48FB-AE47-861A744BE48AQ42594063-600D82A0-002F-4908-85D2-9C2E403A8988Q43064338-D705FF3B-D68A-413E-B50A-0F9DE871DA1BQ43114052-480FE541-4933-4EA5-B801-AD0D2CC64CB3Q43678513-9F10383C-161A-4114-B58B-D31AE2366154Q43823415-51FBDE9F-6C49-4A04-B499-1E4D5CD36561Q43947487-BABEACA9-3EB4-4AF1-95C9-0BBD04A430E8Q44372069-D26FB523-CCC5-4A30-8ABB-8B06632C6483Q44389362-115342A3-124D-477D-898C-7654D6A7F00CQ46077392-A51F1A76-D739-4F62-B7C4-34B9828F622BQ46221207-F1F8AE10-143B-4355-A082-37ACB0C31C6BQ46668294-C5140DC8-D229-4EEB-8D93-727D0B4F7DD3Q47772637-53E7174D-86EE-4E00-BC46-721CCE3CA3F7Q47813282-5B52AC61-A4AD-499C-BCB0-EAA6B4CD1B93Q47955958-27571DE4-CD02-47A2-ACE0-B44887595E46Q48358253-06B7DB99-80A7-436F-804A-06689B9BF748Q48371217-EA32296B-BCFF-4869-B19B-2E6790516BE3Q48538238-A6C01252-EA2C-44D8-86C1-D7539A0D1629Q48591712-BC0AD072-0564-4032-BEC4-D44238DA5A5AQ48865850-41FC7E89-B4E7-4815-985F-4B9CD227C6D8Q50991781-FF8F3C7B-946A-451F-A037-9BCF4CEB6047Q51110213-B20261BA-9F48-47C1-8E0C-A46B569E67D3Q51857287-7A3BADC3-F812-4EC2-BDE8-94BA82D9C687Q52906302-CE32AB2E-DDC3-4599-AEDA-08F95FF8E9A8Q53172840-21542E92-58F5-496B-85EB-E874224081E2Q53727811-D9FF06FF-3E47-4D00-80A8-F4CE6B5696EDQ56883844-DA96277B-9FED-4E97-AE78-F43C5AD86E6EQ90982386-D072ACA7-C3C3-4339-BC29-E47E9F729269Q90985058-79D09EEC-CF2C-4B2B-96A6-48C0FFCDE16D
P50
description
onderzoeker
@nl
researcher ORCID id 0000-0001-9563-6762
@en
name
F.J. Snoek
@ast
F.J. Snoek
@es
F.J. Snoek
@nl
Frank Snoek
@en
Frank Snoek
@pt
type
label
F.J. Snoek
@ast
F.J. Snoek
@es
F.J. Snoek
@nl
Frank Snoek
@en
Frank Snoek
@pt
altLabel
F.J. Snoek
@en
prefLabel
F.J. Snoek
@ast
F.J. Snoek
@es
F.J. Snoek
@nl
Frank Snoek
@en
Frank Snoek
@pt
P106
P21
P31
P496
0000-0001-9563-6762